Authors: Harland, M Mistry, S Bishop, DT Bishop, JAN

Citation: M. Harland et al., A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees, HUM MOL GEN, 10(23), 2001, pp. 2679-2686

Authors: Randerson-Moor, JA Harland, M Williams, S Cuthbert-Heavens, D Sheridan, E Aveyard, J Sibley, K Whitaker, L Knowles, M Bishop, JN Bishop, DT

Citation: Ja. Randerson-moor et al., A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural systemtumour syndrome family, HUM MOL GEN, 10(1), 2001, pp. 55-62

Authors: Harland, M Holland, EA Ghiorzo, P Mantelli, M Bianchi-Scarra, G Goldstein, AM Tucker, MA Ponder, BAJ Mann, GJ Bishop, DT Bishop, JN

Citation: M. Harland et al., Mutation screening of the CDKN2A promoter in melanoma families, GENE CHROM, 28(1), 2000, pp. 45-57

Authors: Bishop, JAN Wachsmuth, RC Harland, M Bataille, V Pinney, E Mack, P Baglietto, L Cuzick, J Bishop, DT

Citation: Jan. Bishop et al., Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations, J INVES DER, 114(1), 2000, pp. 28-33

Authors: Bishop, JAN Harland, M Bennett, DC Bataille, V Goldstein, AM Tucker, MA Ponder, BAJ Cuzick, J Selby, P Bishop, DT

Citation: Jan. Bishop et al., Mutation testing in melanoma families: INK4A, CDK4 and INK4D, BR J CANC, 80(1-2), 1999, pp. 295-300

Authors: Bishop, JAN Harland, M Bishop, DT

Citation: Jan. Bishop et al., The genetics of melanoma: the UK experience, CLIN EXP D, 23(4), 1998, pp. 158-161